Literature DB >> 8316228

Roles of sulfhydryl and disulfide groups in the binding of CP-55,940 to rat brain cannabinoid receptor.

R Lu1, J R Hubbard, B R Martin, M Y Kalimi.   

Abstract

The roles of sulfhydryl and disulfide groups in the specific binding of synthetic cannabinoid CP-55,940 to the cannabinoid receptor in membrane preparations from the rat cerebral cortex have been examined. Various sulfhydryl blocking reagents including p-chloromercuribenzoic acid (p-CMB), N-ethylmaleimide (NEM), o-iodosobenzoic acid (o-ISB), and methyl methanethiosulfonate (MMTS) inhibited the specific binding of [3H]CP-55,940 to the cannabinoid receptor in a dose-dependent manner. About 80-95% inhibition was obtained at a 0.1 mM concentration of these reagents. Scatchard analysis of saturation experiments indicates that most of these sulfhydryl modifying reagents reduce both the binding affinity (Kd) and capacity (Bmax). On the other hand, DL-dithiothreitol (DTT), a disulfide reducing agent, also irreversibly inhibited the specific binding of [3H]CP-55,940 to the receptor and about 50% inhibition was obtained at a 5 mM concentration. Furthermore, 5 mM DTT was abelt to dissociate 50% of the bound ligand from the ligand-receptor complex. The marked inhibition of [3H]CP-55,940 binding by sulfhydryl reagents suggests that at least one free sulfhydryl group is essential to the binding of the ligand to the receptor. In addition, the inhibition of the binding by DTT implies that besides free sulfhydryl group(s), the integrity of a disulfide bridge is also important for [3H]CP-55,940 binding to the cannabinoid receptor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8316228     DOI: 10.1007/bf00925970

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  44 in total

1.  Evidence for disulfide bonds in membrane-bound and solubilized opioid receptors.

Authors:  K Kamikubo; H Murase; M Murayama; M Matsuda; K Miura
Journal:  J Neurochem       Date:  1988-02       Impact factor: 5.372

Review 2.  The cannabinoid receptor: biochemical and cellular properties in neuroblastoma cells.

Authors:  A C Howlett; T M Champion-Dorow; L L McMahon; T M Westlake
Journal:  Pharmacol Biochem Behav       Date:  1991-11       Impact factor: 3.533

3.  Multiple reactive sulfhydryl groups modulate the function of adenylate cyclase coupled beta-adrenergic receptors.

Authors:  J M Stadel; R J Lefkowitz
Journal:  Mol Pharmacol       Date:  1979-11       Impact factor: 4.436

4.  Specific labeling of rat brain substance P receptor with [3H]physalaemin.

Authors:  P Mohini; S W Bahouth; D E Brundish; J M Musacchio
Journal:  J Neurosci       Date:  1985-08       Impact factor: 6.167

5.  Specific covalent modification of thiols: applications in the study of enzymes and other biomolecules.

Authors:  K Brocklehurst
Journal:  Int J Biochem       Date:  1979

6.  Effect of disulfide-bond reducing agents on the specific binding of growth hormone to microsomal membrane preparations from rabbit liver.

Authors:  A C Herington
Journal:  Biochem Pharmacol       Date:  1986-04-15       Impact factor: 5.858

7.  Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.

Authors:  C A Stratford; G L Tan; M W Hamblin; R D Ciaranello
Journal:  Mol Pharmacol       Date:  1988-10       Impact factor: 4.436

8.  Sulfhydryl groups are involved in the interaction of FSH with its receptor.

Authors:  T A Santa-Coloma; P Grasso; L E Reichert
Journal:  Biochem Biophys Res Commun       Date:  1991-05-15       Impact factor: 3.575

9.  Effects of heavy metal cations and other sulfhydryl reagents on brain dopamine D1 receptors: evidence for involvement of a thiol group in the conformation of the active site.

Authors:  C Braestrup; P H Andersen
Journal:  J Neurochem       Date:  1987-06       Impact factor: 5.372

10.  Alpha-1 and alpha-2 adrenoceptor binding in cerebral cortex: role of disulfide and sulfhydryl groups.

Authors:  T A Reader; R Brière; L Grondin
Journal:  Neurochem Res       Date:  1986-01       Impact factor: 3.996

View more
  8 in total

1.  Identification and characterization of a novel synthetic cannabinoid CP 55,940 binder in rat brain cytosol.

Authors:  J Qureshi; M Saady; A Cardounel; M Kalimi
Journal:  Mol Cell Biochem       Date:  1998-04       Impact factor: 3.396

Review 2.  Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targets.

Authors:  Srikrishnan Mallipeddi; David R Janero; Nikolai Zvonok; Alexandros Makriyannis
Journal:  Biochem Pharmacol       Date:  2016-11-24       Impact factor: 5.858

3.  Distinct second extracellular loop structures of the brain cannabinoid CB(1) receptor: implication in ligand binding and receptor function.

Authors:  Joong-Youn Shim; James Rudd; Tomas T Ding
Journal:  Proteins       Date:  2011-02

Review 4.  Understanding functional residues of the cannabinoid CB1.

Authors:  Joong-Youn Shim
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

Review 5.  The pharmacology of the cannabinoid system--a question of efficacy and selectivity.

Authors:  Christopher J Fowler
Journal:  Mol Neurobiol       Date:  2007-07-07       Impact factor: 5.590

6.  Glutathione induces neuronal differentiation in rat bone marrow stromal cells.

Authors:  Jun-ichi Sagara; Nobuo Makino
Journal:  Neurochem Res       Date:  2007-06-27       Impact factor: 3.996

7.  Cysteine: a novel neural inducer for rat bone marrow mesenchymal stem cells.

Authors:  Malek Soleimani Mehranjani; Milad Falahat Chian
Journal:  Cell J       Date:  2014-05-25       Impact factor: 2.479

8.  Binding mode prediction of conformationally restricted anandamide analogs within the CB1 receptor.

Authors:  Lea W Padgett; Allyn C Howlett; Joong-Youn Shim
Journal:  J Mol Signal       Date:  2008-02-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.